MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fcvm.2026.1685861

Медицинская библиотека · Frontiers in cardiovascular medicine · 2026

Platelet-derived mediators in hospitalized COVID-19 patients and associations to respiratory failure, ICU admittance and 60-day mortality.

Otterdal Kari, Ueland Thor, Holter Jan Cato, Kaarbø Mari, Schanke Ylva, Granerud Beathe Kiland, Dahl Tuva B, Tveita Anders, Kildal Anders Benjamin, Heggelund Lars, Aamodt Anne Hege, Holten Aleksander Rygh, Tonby Kristian, Aukrust Pål, Dyrhol-Riise Anne Ma, Halvorsen Bente, Michelsen Annika E

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Platelet activation is documented in COVID-19, but data on platelet-derived mediators are scarce.

OBJECTIVE

To examine the levels of various platelet-derived mediators in relation to adverse outcomes defined as the need for treatment at intensive care unit (ICU) and/or respiratory failure (RF) and 60-day total mortality in hospitalized COVID-19 patients.

METHODS

Plasma levels of RANTES/CCL5, PF4/CXCL4, ENA78/CXCL5, NAP-2/CXCL7, SDF-1/CXCL12, P-selectin, soluble CD40 ligand (sCD40L) and vascular endothelial cell growth factor A (VEGF-A) were measured in 245 hospitalized COVID-19 patients and in a subpopulation of the patients, also at three, six and 12 months after hospitalization.

RESULTS

Our main findings were: (i) High levels of P-selectin was associated with ICU/RF, while low levels of PF4/CXCL4, ENA-78/CXCL5 and NAP-2/CXCL7 were associated with 60-days mortality. (ii) Most of the mediators were normalized after hospitalization, but plasma levels of sCD40L, ENA-78/CXCL7 and VEGF-A were markedly elevated compared to healthy controls for up to 12 months after hospitalization. (iii) In vitro, inactivated SARS-CoV-2 induced a dose-dependent release of NAP-2, P-selectin, RANTES, sCD40L and VEGF-A from isolated platelets.

CONCLUSION

Our findings underscore the role of platelet-derived inflammatory mediators in the pathogenesis of COVID-19, potentially involving direct effects of SARS-CoV-2. The study also points to a persistent platelet activation following hospitalization.

Для цитирования: Otterdal Kari, Ueland Thor, Holter Jan Cato, Kaarbø Mari, Schanke Ylva, Granerud Beathe Kiland, Dahl Tuva B, Tveita Anders, Kildal Anders Benjamin, Heggelund Lars, Aamodt Anne Hege, Holten Aleksander Rygh, Tonby Kristian, Aukrust Pål, Dyrhol-Riise Anne Ma, Halvorsen Bente, Michelsen Annika E. Platelet-derived mediators in hospitalized COVID-19 patients and associations to respiratory failure, ICU admittance and 60-day mortality.. Frontiers in cardiovascular medicine. 2026. DOI: 10.3389/fcvm.2026.1685861.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.